Triple

Target class: pharmacovigilance organization
Context triple: [Office of Surveillance and Epidemiology, instanceOf, pharmacovigilance organization]

• A. pharmacovigilance body chosen
  A pharmacovigilance body is an organization responsible for monitoring, assessing, and preventing adverse effects or other drug-related problems to ensure the ongoing safety and effective use of medicines.
• B. organ of the European Medicines Agency
  An organ of the European Medicines Agency is a formal decision-making or advisory body within the EMA’s governance structure, such as its Management Board, Executive Director, or scientific committees, responsible for specific regulatory, administrative, or scientific functions.
• C. organ of the International Council for Harmonisation
  An organ of the International Council for Harmonisation is a formal body or component within the ICH structure that is responsible for developing, coordinating, or overseeing international guidelines and activities related to the harmonisation of pharmaceutical regulation.
• D. U.S. Food and Drug Administration center
  A U.S. Food and Drug Administration center is a specialized organizational unit within the FDA responsible for regulating and overseeing specific categories of products, such as drugs, biologics, medical devices, or food, to ensure their safety, effectiveness, and proper labeling.
• E. public health organisation
  A public health organisation is an entity, typically governmental or non-profit, that plans, implements, and evaluates programs and policies to protect and improve the health of populations.
• F. None of above.